Do-It-Yourself Screening Kits Shipped Directly to Consumers’ Doorsteps; Lab Results Displayed on Secure Web Site.
Santa Barbara, Calif. – April 08, 2008 – The number of Americans at risk for diabetes, heart disease, prostate cancer, colorectal cancer and other common illnesses has increased significantly in recent years, potentially shortening the lifespan of millions and putting an unprecedented strain on the health care system. Fortunately, with early detection and appropriate treatment, the complications and costs related to these diseases can often be minimized. Now thanks to a line of test kits from BioIQ, people can order test kits to monitor cholesterol, blood sugar and other important biometric information. BioIQ also offers corporate health screening programs to bring the benefits of home testing to employers, employees and their dependents, enabling people throughout the U.S. to screen themselves for many of today’s most common and preventable illnesses in the privacy of their own homes.
Participants that have used the BioIQ service report the process is convenient and surprisingly simple. After ordering a test kit online at www.bioiq.com, customers receive the kits at home in a plain white envelope and follow the instructions to supply a few drops of blood via a simple finger prick. Blood samples are routed by mail to certified laboratories for processing. Participants are notified when their personalized results are ready for viewing through secure, password-protected personal health dashboards. All participants receive customized results and are encouraged to share their lab reports with their physicians.
In addition to the company’s home testing service for consumers, BioIQ has created turnkey health-screening programs for employers. Participating companies send one introductory message to their employees and BioIQ handles the rest: encouraging participation, signing up users, shipping test kits, presenting private lab results, and generating HIPAA-compliant aggregate reports for management.
Justin Bellante, co-founder and CEO of BioIQ, said the company’s innovative service is possible due to recent advances in biomedical technology, making it safe, practical and convenient for anyone to conduct self-administered health screening tests. “BioIQ empowers every American to take control of their health with user-friendly diagnostic and risk assessment technology,” said Mr. Bellante. “For the first time, a variety of test results are just a mouse click away in a secure, totally private environment. We’ve made it possible for individuals to obtain critical biometric information and for employers to acquire vital insight into the overall health of their employee populations.”
BioIQ’s current offerings include a Colorectal Cancer Test Kit, a Diabetes Test Kit, a Cholesterol/Heart Disease Test Kit and a combo kit that screens for both diabetes and heart disease. BioIQ will soon offer additional tests to screen for kidney disease, osteoporosis, thyroid disorder and prostate cancer. BioIQ also offers a free online health assessment that considers family history, eating habits, exercise regimen, blood pressure and other lifestyle factors. All personal information is protected under federal HIPAAprivacy regulations and all medical recommendations are based on guidelines from public health institutions such as the U.S. National Institutes of Health and U.S. Centers for Disease Control and Prevention, in conjunction with current insight from BioIQ’s medical advisory board.
Based in Santa Barbara, Calif., BioIQ is a health care information technology company that develops and markets medical diagnostic solutions through corporate, institutional and direct-to-consumer channels. The company’s affordable and innovative home test kits and corporate wellness solutions enable anyone to take meaningful preventive steps to detect chronic diseases in their early stages, often before symptoms occur. Customers use BioIQ products to monitor or screen for diabetes, cancer, heart disease, kidney disease, thyroid disorder, osteoporosis, and other chronic health conditions.
Press Contact: David Baum
BioIQ Press Relations